drugset / Trial / NCT04493918

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection

NCT04493918

Phase 2 Unknown 20 enrolled Ahmad Jabir Rahyussalim
NaSingle-groupOpen-labelTreatment

Summary

This study evaluates the effectiveness of locally implantation of mesenchymal stem cell on vertebral bone defects due to infection of mycobacterium tuberculosis. there are controlled participants who receives placebo and patients who receives implantation of MSc

Timeline

Start
2017-05-21
Primary completion
2020-12-30
Completion
2020-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal stem cell Cell therapy 3e+07 cells Other

Indications